by Eric W. Dolan for PsyPost.org
A new study published in the Journal of Psychopharmacology is the first to characterize the psychological impacts of psilocybin among people with bipolar disorder. The findings indicate that many people with bipolar disorder who consume psilocybin, the primary psychoactive component of psychedelic “magic mushrooms,” believe that the experience is helpful.
Study author Emma Morton explained, “Our survey asked about experiences of psilocybin use outside of clinical settings. Unlike a clinical trial, naturalistic use does not occur in carefully controlled conditions. That means we cannot be sure whether the negative outcomes reported were due to psilocybin use, or something else. ”
“Research into the therapeutic potential of psilocybin has been limited due to its legal status,” Morton added. “Our research therefore relied on asking the community to share their experiences of using psilocybin. It was important for us to show respect and appreciation for people who participated by making the research process accessible, equitable, and representative of people with diverse experiences.”